GSK ILACLARI SAN VE TIC A.S.

Company Introduction:

GSK ILACLARI SAN VE TIC A.S. is the Turkish subsidiary of GlaxoSmithKline, a global science-led healthcare company. It operates in Turkey, focusing on the pharmaceutical sector.

Company Type:

It is primarily a manufacturing company (factory), also engaged in trade.

Details:

GSK ILACLARI SAN VE TIC A.S. is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, vaccines, and consumer healthcare products. As a key player in the Turkish pharmaceutical industry, it contributes to public health by providing innovative medicines and healthcare solutions to the local market and beyond. The "SAN" in its name (Sanayi, meaning Industry) explicitly indicates its manufacturing capabilities.

GSK ILACLARI SAN VE TIC A.S. (GSK Turkey) manufactures or sells a wide range of pharmaceutical products and vaccines across various therapeutic areas. Key product categories and examples include:

1. Respiratory Diseases

* Seretide (for asthma and COPD)

* Relvar Ellipta (for asthma and COPD)

* Nucala (for severe eosinophilic asthma)

* Ventolin (for asthma relief)

2. Vaccines

* Shingrix (for shingles)

* Fluarix (for influenza)

* Synflorix (for pneumococcal disease)

* Infanrix Hexa (for diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b)

* Rotarix (for rotavirus)

3. HIV

* Tivicay (dolutegravir)

* Triumeq (abacavir, dolutegravir, lamivudine)

* Dovato (dolutegravir, lamivudine)

4. Immunology

* Benlysta (for systemic lupus erythematosus)

5. Oncology

* Zejula (niraparib, for ovarian cancer)

* Jemperli (dostarlimab, for endometrial cancer)